Long-term safety and efficacy of daily recombinant human growth hormone treatment in Japanese short children born small for gestational age: final report from an open and multi-center study

Eitemau Tebyg

• Efficacy and Safety of Up to 8 Years of Long-term Growth Hormone Treatment in Short Children Born Small for Gestational Age in Japan: Analysis of the Subpopulation According to the Japanese Guideline
  gan: Tanaka, Toshiaki, et al.
  Cyhoeddwyd: (2012)
• The long-term safety and effectiveness of growth hormone treatment in Japanese children with short stature born small for gestational age
  gan: Horikawa, Reiko, et al.
  Cyhoeddwyd: (2020)
• Onset of puberty and near adult height in short children born small for gestational age and treated with GH: Interim analysis of up to 10 years of treatment in Japan
  gan: Tanaka, Toshiaki, et al.
  Cyhoeddwyd: (2015)
• Onset of puberty and near adult height in short children born small for gestational age and treated with GH: Interim analysis of up to 10 years of treatment in Japan
  gan: Tanaka, Toshiaki, et al.
  Cyhoeddwyd: (2015)
• Evaluation of growth hormone treatment efficacy in short Japanese children born small for gestational age: Five-year treatment outcome and impact on puberty
  gan: Horikawa, Reiko, et al.
  Cyhoeddwyd: (2017)